Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Friedrich

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
European Journal of Immunology|April 6, 2024
Tumor-associated macrophages impair NK cell IFN-γ production and contribute to tumor progression in clear cell renal cell carcinomaSol Yanel Núñez, Aldana Trotta, María Victoria Regge, et al.
Oncoimmunology|August 8, 2022
The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncologyFlorencia Secchiari, Sol Yanel Nuñez, Jessica Mariel Sierra, et al.
Journal for Immunotherapy of Cancer|June 11, 2020
Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric proteinNicolas Torres, María Victoria Regge, Florencia Secchiari, et al.
The Journal of Infectious Diseases|October 18, 2015
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083Stephen R Walsh, Zoe Moodie, Andrew J Fiore-Gartland, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
European Journal of Immunology|April 6, 2024
Tumor-associated macrophages impair NK cell IFN-γ production and contribute to tumor progression in clear cell renal cell carcinomaSol Yanel Núñez, Aldana Trotta, María Victoria Regge, et al.
Oncoimmunology|August 8, 2022
The MICA-NKG2D axis in clear cell renal cell carcinoma bolsters MICA as target in immuno-oncologyFlorencia Secchiari, Sol Yanel Nuñez, Jessica Mariel Sierra, et al.
Journal for Immunotherapy of Cancer|June 11, 2020
Restoration of antitumor immunity through anti-MICA antibodies elicited with a chimeric proteinNicolas Torres, María Victoria Regge, Florencia Secchiari, et al.
The Journal of Infectious Diseases|October 18, 2015
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083Stephen R Walsh, Zoe Moodie, Andrew J Fiore-Gartland, et al.
Pageof 3